Progesterone Receptor Negative Recruiting Phase 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02876107Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast CancerTreatment
NCT02957968Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast CaTreatment
NCT02593175Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBCTreatment